Viyash Scientific · NSE: VIYASH · BSE: 512529
Q4 FY21 results · Jan–Mar 2021
Viyash Scientific reported revenue from operations of ₹361.82 crore (up 20.4% from Q4 FY20) and net profit of ₹23.52 crore (up 29.1% from Q4 FY20) for Q4 FY21 (Jan–Mar 2021), on a consolidated basis.
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 361.82 | 300.58 | +20.4% | 358.21 | +1.0% |
| Other income | 1.37 | 1.82 | −24.9% | 2.81 | −51.2% |
| Total income | 363.20 | 302.41 | +20.1% | 361.02 | +0.6% |
| Profit before tax | 29.01 | 24.14 | +20.2% | 51.33 | −43.5% |
| Net profit for the period | 23.52 | 18.23 | +29.1% | 39.69 | −40.7% |
| Attributable to shareholders of the company | 20.63 | 16.86 | +22.4% | 37.23 | −44.6% |
| EPS, basic (₹) | 0.84 | 0.69 | +21.7% | 1.52 | −44.7% |
| Net margin (%) | 6.5 | 6.1 | 11.1 |
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 69.48 | 62.29 | +11.5% | 70.57 | −1.5% |
| Other income | 5.92 | 3.05 | +93.9% | 5.67 | +4.4% |
| Total income | 75.40 | 65.35 | +15.4% | 76.24 | −1.1% |
| Profit before tax | 6.03 | 10.06 | −40.0% | 16.11 | −62.6% |
| Net profit for the period | 4.64 | 6.82 | −31.9% | 12.17 | −61.8% |
| EPS, basic (₹) | 0.19 | 0.28 | −32.1% | 0.50 | −62.0% |
| Net margin (%) | 6.7 | 10.9 | 17.2 |
Consolidated
- Filed with BSE
- 01 Jul 2021, 20:51 IST
- Board meeting
- 30 Jun 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 01 Jul 2021, 20:51 IST
- Board meeting
- 30 Jun 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Audited
- Source
- XBRL filing on BSE